| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MBX Biosciences, Inc. | Director | Common Stock | 2,136,335 | $22,837,421 | $10.69 | 16 Sep 2024 | By Norwest Venture Partners XVI, LP |
| SPRUCE BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 30,000 | 22 Jul 2025 | Direct | ||
| MBX Biosciences, Inc. | Director | Stock option (right to buy) | 16,000 | 05 Jun 2025 | Direct | ||
| Nkarta, Inc. | Director | Stock Option (right to buy) | 16,000 | 08 Jun 2022 | Direct | ||
| MBX Biosciences, Inc. | Director | Series B Convertible Preferred Stock | 0 | 16 Sep 2024 | By Norwest Venture Partners XVI, LP |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRB | SPRUCE BIOSCIENCES, INC. | 22 Jul 2025 | 1 | $0 | 4 | Director | 24 Jul 2025, 19:35 |
| MBX | MBX Biosciences, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 08:05 |
| MBX | MBX Biosciences, Inc. | 16 Sep 2024 | 3 | +$12,000,000 | 4 | Director | 17 Sep 2024, 20:05 |
| MBX | MBX Biosciences, Inc. | 12 Sep 2024 | 1 | $0 | 4 | Director | 13 Sep 2024, 17:04 |
| MBX | MBX Biosciences, Inc. | 12 Sep 2024 | 0 | $0 | 3 | Director | 12 Sep 2024, 19:17 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 22 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 16:23 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 25 May 2023 | 1 | $0 | 4 | Director | 26 May 2023, 17:35 |
| NKTX | Nkarta, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:03 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 25 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 16:19 |